Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2

H Jacobsen, I Sitaras, M Katzmarzyk, V Cobos Jiménez… - npj Vaccines, 2023 - nature.com
Mass COVID-19 vaccination and continued introduction of new SARS-CoV-2 variants
increased prevalence of hybrid immunity at various stages of waning protection. We …

Neutralization against BA. 2.75. 2, BQ. 1.1, and XBB from mRNA Bivalent Booster

ME Davis-Gardner, L Lai, B Wali… - … England Journal of …, 2023 - Mass Medical Soc
Omicron Neutralization after Bivalent Vaccine Boost One or two monovalent vaccine
boosters showed a large decrease in neutralization activity against omicron subvariants …

Virological characteristics of the SARS-CoV-2 Omicron BA. 2 subvariants, including BA. 4 and BA. 5

I Kimura, D Yamasoba, T Tamura, N Nao, T Suzuki… - Cell, 2022 - cell.com
After the global spread of the SARS-CoV-2 Omicron BA. 2, some BA. 2 subvariants,
including BA. 2.9. 1, BA. 2.11, BA. 2.12. 1, BA. 4, and BA. 5, emerged in multiple countries …

Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines

J Zhou, Z Liu, G Zhang, W Xu, L Xing… - Journal of Medical …, 2023 - Wiley Online Library
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
variants with high transmission rates and striking immune evasion have posed a serious …

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

AR Branche, NG Rouphael, DJ Diemert, AR Falsey… - Nature medicine, 2023 - nature.com
Vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection wanes over time, requiring updated boosters. In a phase 2, open-label, randomized …

Mapping SARS-CoV-2 antigenic relationships and serological responses

SH Wilks, B Mühlemann, X Shen, S Türeli… - Science, 2023 - science.org
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
multiple variants escaping preexisting immunity emerged, causing reinfections of previously …

Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA. 4 and BA. 5 compared with previous waves in the …

MA Davies, E Morden, P Rousseau, J Arendse… - International Journal of …, 2023 - Elsevier
Objectives We aimed to compare the clinical severity of Omicron BA. 4/BA. 5 infection with
BA. 1 and earlier variant infections among laboratory-confirmed SARS-CoV-2 cases in the …

Enhanced neutralization of SARS-CoV-2 variant BA. 2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster

X Wang, S Jiang, W Ma, X Li, K Wei, F Xie, C Zhao… - Cell host & …, 2024 - cell.com
Summary Emerging SARS-CoV-2 sub-lineages like XBB. 1.5, XBB. 1.16, EG. 5, HK. 3 (FLip),
and XBB. 2.3 and the variant BA. 2.86 have recently been identified. Understanding the …

Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo …

K Hardt, A Vandebosch, J Sadoff, M Le Gars… - The Lancet Infectious …, 2022 - thelancet.com
Background Despite the availability of effective vaccines against COVID-19, booster
vaccinations are needed to maintain vaccine-induced protection against variant strains and …

Insights from an N3C RECOVER EHR-based cohort study characterizing SARS-CoV-2 reinfections and Long COVID

E Hadley, YJ Yoo, S Patel, A Zhou, B Laraway… - Communications …, 2024 - nature.com
Background Although the COVID-19 pandemic has persisted for over 3 years, reinfections
with SARS-CoV-2 are not well understood. We aim to characterize reinfection, understand …